Replies to post #421109 on Amarin Corp Plc (AMRN)

[JRoon71]

Again, Teva is NOT dropping out of the generics business. They are selling their API manufacturing unit ONLY. They STILL own the generics unit, and have no plans of divesting that.

And even if they DO, whoever buys it will keep distributing all the same drugs.

This is a non-event for Amarin or the generics market.

[johnhancoque]

We don't want more to drop out of the ipe race. That would be a boon for Hikma and Reddys. We want more generic competition for ipe because it squeezes those 2 clowns out of the market. Any dropouts will be a boon for Reddys and Hikma. As far as I'm concerned I hope we see another 10 generics come aboard this year because the more there are of them the slimmer the pie each take. Aimho